Richard C. Mulligan (born 1954) is an American scientist who is the Mallinckrodt Professor of Genetics at Harvard Medical School,[1][2][3] the Director of the Harvard Gene Therapy Initiative and a visiting scientist at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology.
He would earn his PhD in biochemistry at Stanford University in 1980 working with Paul Berg to develop viral vectors to express human and bacterial genes.
[6][7] He would then do his postdoctoral training at the Center for Cancer Research at MIT with David Baltimore and Phillip Sharp.
He would join the faculty of molecular biology and was a member of the Whitehead Institute for Biomedical Research.
[8] During that time, he was a founding member of the Recombinant DNA Advisory Committee (RAC).